These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8958892

  • 1. Salmeterol tachyphylaxis in steroid treated asthmatic subjects.
    Booth H, Bish R, Walters J, Whitehead F, Walters EH.
    Thorax; 1996 Nov; 51(11):1100-4. PubMed ID: 8958892
    [Abstract] [Full Text] [Related]

  • 2. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S, Swystun VA, Bhagat R, Cockcroft DW.
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [Abstract] [Full Text] [Related]

  • 4. Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients.
    Booth H, Fishwick K, Harkawat R, Devereux G, Hendrick DJ, Walters EH.
    Thorax; 1993 Nov; 48(11):1121-4. PubMed ID: 8296255
    [Abstract] [Full Text] [Related]

  • 5. Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction.
    Boulet LP, Turcotte H, Cartier A, Milot J, Côté J, Malo JL, Laviolette M.
    Chest; 1998 Aug; 114(2):373-9. PubMed ID: 9726717
    [Abstract] [Full Text] [Related]

  • 6. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids.
    Boulet LP, Cartier A, Milot J, Côté J, Malo JL, Laviolette M.
    Eur Respir J; 1998 May; 11(5):1091-7. PubMed ID: 9648961
    [Abstract] [Full Text] [Related]

  • 7. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH, Kharitonov SA, Barnes PJ.
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [Abstract] [Full Text] [Related]

  • 8. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ, Winter TH, Aalbers R.
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [Abstract] [Full Text] [Related]

  • 9. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [Abstract] [Full Text] [Related]

  • 10. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I, Lipworth BJ.
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ.
    N Engl J Med; 1992 Oct 22; 327(17):1198-203. PubMed ID: 1357550
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan 22; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 13. Acute bronchodilatory effect of salmeterol on methacholine-induced bronchoconstriction in childhood asthma.
    Baki A, Karagüzel G.
    Acta Paediatr Jpn; 1998 Apr 22; 40(2):135-7. PubMed ID: 9581303
    [Abstract] [Full Text] [Related]

  • 14. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
    Wilding P, Clark M, Thompson Coon J, Lewis S, Rushton L, Bennett J, Oborne J, Cooper S, Tattersfield AE.
    BMJ; 1997 May 17; 314(7092):1441-6. PubMed ID: 9167559
    [Abstract] [Full Text] [Related]

  • 15. Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.
    Wong AG, O'Shaughnessy AD, Walker CM, Sears MR.
    Eur Respir J; 1997 Feb 17; 10(2):330-6. PubMed ID: 9042628
    [Abstract] [Full Text] [Related]

  • 16. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.
    JAMA; 1994 May 11; 271(18):1412-6. PubMed ID: 7909853
    [Abstract] [Full Text] [Related]

  • 17. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
    Bhagat R, Kalra S, Swystun VA, Cockcroft DW.
    Chest; 1995 Nov 11; 108(5):1235-9. PubMed ID: 7587422
    [Abstract] [Full Text] [Related]

  • 18. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH, Worsdell M, Barnes PJ.
    Am J Respir Crit Care Med; 1997 Sep 11; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [Abstract] [Full Text] [Related]

  • 19. An overview of nine clinical trials of salmeterol in an asthmatic population.
    Verberne AA, Fuller R.
    Respir Med; 1998 May 11; 92(5):777-82. PubMed ID: 9713640
    [Abstract] [Full Text] [Related]

  • 20. Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics.
    Nielsen LP, Pedersen B, Faurschou P, Madsen F, Wilcke JT, Dahl R.
    Respir Med; 1999 Dec 11; 93(12):863-8. PubMed ID: 10653047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.